Ying-syuan Li

92, Chung Shan North Road, 104217
TPQ 10421, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Incomplete radiofrequency ablation may elicit pro-oncogenic effects in thyroid cancer cells in a xenograft mouse model.

Incomplete radiofrequency ablation may elicit pro-oncogenic effects in thyroid cancer cells in a xenograft mouse model.

Journal: Biology direct

Published: February 19, 2026

Glucose Transporter 1 Inhibitors Induce Autophagy and Synergize With Lenvatinib in Thyroid Cancer Cells.

Glucose Transporter 1 Inhibitors Induce Autophagy and Synergize With Lenvatinib in Thyroid Cancer Cells.

Journal: Head & neck

Published: June 15, 2024

SOX4 is a pivotal regulator of tumorigenesis in differentiated thyroid cancer.

SOX4 is a pivotal regulator of tumorigenesis in differentiated thyroid cancer.

Journal: Molecular and cellular endocrinology

Published: July 08, 2023

Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer.

Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer.

Journal: Molecular carcinogenesis

Published: April 16, 2023

CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway.

CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway.

Journal: Endocrinology

Published: August 19, 2022

ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells.

ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells.

Journal: Endocrine

Published: March 29, 2022

Galectin-3 Inhibitors Suppress Anoikis Resistance and Invasive Capacity in Thyroid Cancer Cells.

Galectin-3 Inhibitors Suppress Anoikis Resistance and Invasive Capacity in Thyroid Cancer Cells.

Journal: International journal of endocrinology

Published: February 14, 2021

Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer.

Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer.

Journal: The Journal of pathology

Published: March 13, 2020

Ethacridine Induces Apoptosis and Differentiation in Thyroid Cancer Cells In Vitro.

Ethacridine Induces Apoptosis and Differentiation in Thyroid Cancer Cells In Vitro.

Journal: Anticancer research

Published: May 26, 2019

Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay.

Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay.

Journal: Frontiers in neurology

Published: April 12, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026